异动解读 | 诺瓦瓦克斯医药盘中大跌6.72% 财报不佳影响股价

异动解读
10 Jan

生物技术公司诺瓦瓦克斯医药(NVAX)今日盘中股价大跌6.72%,引发投资者关注。

根据最新财报数据,诺瓦瓦克斯医药营业收入仅为8451万美元,净利润却亏损1.21亿美元,每股亏损0.76美元。财报表现不佳或是导致股价下跌的主要原因。

不过目前该股获买入评级占一半,显示机构对其长期前景仍保持乐观态度。但由于最新财报不达预期,短期内或将持续承压。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10